Liquid Biopsy
News and reporting on cell-free DNA testing.
Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project
The firm will provide testing using its HCCscreen assay and help develop follow-up procedures as part of an effort to advance cancer early detection in rural areas of China.
Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection
Premium
The technology, developed by researchers at Stanford, showed strong performance in a new study of lymphoma, and early data for solid tumors is already available.
European Commission Opens In-Depth Investigation of $8B Illumina-Grail Merger
Illumina has reiterated its commitment to see the deal through, noting it has offered structural and behavioral remedies to address any concerns.
Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study
Premium
Investigators analyzed blood samples from patients at two time points after curative-intent surgery, finding that ctDNA MRD status was highly predictive of outcome.
Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests
Under the LCD, CTC assays, such as Biocept's, will now be covered to guide targeted treatment decisions for patients with breast and other cancers under certain circumstances.